Attached files

file filename
EX-99.2 - EX-99.2 - HEALTHPEAK PROPERTIES, INC.a12-4755_1ex99d2.htm
8-K - 8-K - HEALTHPEAK PROPERTIES, INC.a12-4755_18k.htm

Exhibit 99.1

 

 

 

 

FOR IMMEDIATE RELEASE

 

 

 

HCP ANNOUNCES RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2011

 

FOURTH QUARTER HIGHLIGHTS

 

--                Diluted FFO per share was $0.37, net of a litigation settlement charge; diluted FFO as adjusted per share was $0.67; diluted FAD per share was $0.50; and diluted earnings per share was $0.15

 

--                Year-over-year three-month adjusted NOI Same Property Performance increased 2.2%

 

--                Subsequent to year end:

 

--  Executed a lease amendment that expands Google’s footprint at our Mountain View campus to a total of 290,000 sq. ft.

 

--  Completed a $450 million public offering of 3.75% senior unsecured notes due 2019

 

--  Declared quarterly common stock dividend of $0.50, annualized to $2.00 for 2012, representing a 4.2% increase over 2011 and the 27th consecutive year with a dividend increase

 

FULL YEAR HIGHLIGHTS

 

--                Diluted FFO per share decreased 3% to $2.19; diluted FFO as adjusted per share increased 21% to $2.69; diluted FAD per share increased 13% to $2.14; and diluted earnings per share increased 29% to $1.29

 

--                Achieved total shareholder returns for one year of 18.7% and two years of 51.3% for periods ending December 31, 2011

 

--                Year-over-year adjusted NOI Same Property Performance increased 4.0%

 

--                Completed 2.8 million sq. ft. of medical office and life science leasing with a retention rate of 75%, resulting in an increase in occupancy to 91%

 

--                Closed $7.0 billion of investments, led by our $6.1 billion acquisition of HCR ManorCare’s real estate assets, for which we replaced the stock consideration due to the seller valued at $33.14 per share with cash

 

--    Executed five senior housing loan commitments to fund a total of $101 million of construction financing

 

--    Accessed the public markets to raise over $3.7 billion in capital and renewed our $1.5 billion revolving line of credit facility

 

--                Obtained credit upgrades from Fitch and Moody’s and placed on positive credit watch by S&P

 

--                Received $330 million from the early payoff of our Genesis debt investments, realizing a 40% annualized internal rate of return

 

--                Continued to lead in sustainability as recognized by the U.S. Environmental Protection Agency and NAREIT

 

Page 1 of 11



 

LONG BEACH, CA, February 14, 2012 -- HCP (the “Company” or “we”) (NYSE:HCP) announced results for the fourth quarter and year ended December 31, 2011 as follows (in thousands, except per share amounts):

 

Fourth Quarter Comparison

 

 

 

Three Months Ended
December 31, 2011

 

Three Months Ended
December 31, 2010

 

Per Share

 

 

 

Amount

 

Per Share

 

Amount

 

Per Share

 

Change

 

FFO

 

$

150,578

 

$

0.37

 

$

202,611

 

$

0.62

 

$

(0.25

)

Litigation settlement charge(1)

 

125,000

 

0.30

 

 

 

0.30

 

Merger-related items(2)

 

 

 

4,339

 

0.02

 

(0.02

)

FFO as adjusted

 

$

275,578

 

$

0.67

 

$

206,950

 

$

0.64

 

$

0.03

 

FAD

 

$

202,890

 

$

0.50

 

$

171,292

 

$

0.53

 

$

(0.03

)

Net income applicable to common shares

 

$

61,996

 

$

0.15

 

$

136,202

 

$

0.42

 

$

(0.27

)

 


(1)  This charge during the quarter ended December 31, 2011 relates to the Ventas, Inc. (“Ventas”) litigation settlement. See the “Litigation” section of this release for additional information regarding this settlement.

(2)  See the “Funds From Operations” section of this release for additional information regarding merger-related items.

 

In addition to the litigation settlement charge, operating results for the quarter ended December 31, 2011, include the negative impact of $0.01 per share for the write-down in the carrying value of a marketable security. In addition to the merger-related items, operating results for the quarter ended December 31, 2010, include the positive impact of $0.06 per share from the following: (i) other income of $0.03 per share related to gain on sales of marketable securities and (ii) interest income of $0.03 per share from the early repayment of a mortgage loan receivable.

 

Full Year Comparison

 

 

 

Year Ended
December 31, 2011

 

Year Ended
December 31, 2010

 

Per Share

 

 

 

Amount

 

Per Share

 

Amount

 

Per Share

 

Change

 

FFO(1)

 

$

877,907

 

$

2.19

 

$

690,637

 

$

2.25

 

$

(0.06

)

Litigation settlement charge(2)

 

125,000

 

0.31

 

 

 

0.31

 

Other impairments (recoveries)(3)

 

15,400

 

0.04

 

(11,900

)

(0.04

)

0.08

 

Merger-related items(3)

 

26,596

 

0.15

 

4,339

 

0.02

 

0.13

 

FFO as adjusted

 

$

1,044,903

 

$

2.69

 

$

683,076

 

$

2.23

 

$

0.46

 

FAD

 

$

830,651

 

$

2.14

 

$

578,452

 

$

1.89

 

$

0.25

 

Net income applicable to common shares

 

$

515,302

 

$

1.29

 

$

307,498

 

$

1.00

 

$

0.29

 

 


(1)  NAREIT recently issued updated reporting guidance that directs companies, for their computation of NAREIT FFO, to exclude impairments of depreciable real estate and other assets when write-downs are driven by measurable decreases in the fair value of real estate holdings (e.g., investments in joint ventures that primarily hold real estate). Previously, the Company’s calculation of FFO (consistent with NAREIT’s previous guidance) did not exclude impairments of, or related to, depreciable real estate. Consistent with this current NAREIT reporting guidance, the Company has restated its 2010 FFO amounts.

(2)  This charge during the year ended December 31, 2011 relates to the Ventas litigation settlement. See the “Litigation” section of this release for additional information regarding this settlement.

(3)  See the “Funds From Operations” section of this release for additional information regarding impairments or recoveries of non-depreciable assets (“other impairments”) and merger-related items.

 

FFO, FFO as adjusted and FAD are supplemental non-GAAP financial measures that the Company believes are helpful in evaluating the operating performance of real estate investment trusts. See the “Funds From Operations” section of this release for additional information regarding FFO and FFO as adjusted and the “Funds Available for Distribution” section for additional information regarding FAD.

 

INVESTMENT TRANSACTIONS

 

During the quarter ended December 31, 2011, we made investments of $40 million to fund development and other capital projects, primarily in our life science and medical office segments. During the quarter ended December 31, 2011, we executed two loan commitments to fund up to $35 million of senior housing development.

 

During the three months ended December 31, 2011, we sold three senior housing facilities for $19 million, recognizing gain on sales of real estate of $3.1 million.

 

Page 2 of 11



 

LITIGATION

 

On November 9, 2011, we entered into an agreement with Ventas, Inc. to settle all remaining claims relating to Ventas’s litigation against HCP arising out of Ventas’s 2007 acquisition of Sunrise Senior Living REIT. We paid $125 million to Ventas and incurred a charge during the quarter ended December 31, 2011 for the amount paid.

 

SUSTAINABILITY

 

HCP’s 2011 sustainability accomplishments include the following: (i) earned 29 ENERGY STAR certifications in its medical office (17), life science (7) and senior housing (5) segments; (ii) recognized in May 2011 by ENERGY STAR as the leader in ENERGY STAR certifications for the MOB category; and (iii) awarded NAREIT’s “Leader in the Light” Innovator Award, which recognizes companies demonstrating excellence in energy efficiency.

 

FINANCING

 

On January 23, 2012, we issued $450 million of 3.75% senior unsecured notes due 2019; net proceeds from the offering were $444 million.

 

OTHER EVENTS

 

On February 7, 2012, we executed a lease amendment with Google to expand its footprint at our Mountain View campus to a total of 290,000 sq. ft. Under the terms of this amendment, Google will: (i) lease an additional 41,000 sq. ft. building for a term of 10 years, resulting in a mark-to-market rent increase of 17%; and (ii) extend the term on 124,000 sq. ft. through 2022 (coterminous with the expansion). The terms of the remaining 125,000 sq. ft. leased to 2021 were unchanged.

 

DIVIDEND

 

On January 26, 2012, we announced that our Board of Directors declared a quarterly cash dividend of $0.50 per common share. The dividend will be paid on February 22, 2012 to stockholders of record as of the close of business on February 6, 2012. The annualized distribution rate for 2012 is $2.00, compared to $1.92 for 2011, which represents an increase of 4.2%.

 

OUTLOOK

 

For the full year 2012, we expect FFO applicable to common shares to range between $2.70 and $2.76 per share; FAD applicable to common shares to range between $2.14 and $2.20 per share; and net income applicable to common shares to range between $1.81 and $1.87 per share. These estimates do not reflect, among other things, the potential impact of future acquisitions or dispositions. See Projected Future Operations section of this release for additional information regarding these estimates.

 

COMPANY INFORMATION

 

HCP has scheduled a conference call and webcast for Tuesday, February 14, 2012 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) in order to present the Company’s performance and operating results for the quarter and year ended December 31, 2011. The conference call is accessible by dialing (877) 724-7556 (U.S.) or (706) 645-4695 (International). The participant passcode is 42163539. The webcast is accessible via the Company’s website at www.hcpi.com. This link can be found on the “Event Calendar” page, which is under the “Investor Relations” tab. Through February 28, 2012, an archive of the webcast will be available on our website and a telephonic replay can be accessed by calling (855) 859-2056 (U.S.) or (404) 537-3406 (International) and entering passcode 42163539. The Company’s supplemental information package for the current period will also be available on the Company’s website in the “Presentations” section of the “Investor Relations” tab.

 

ABOUT HCP

 

HCP, Inc. (NYSE:HCP) is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States. The Company’s portfolio of assets is diversified among five distinct sectors: senior housing, post-acute/skilled nursing, life science, medical office and hospitals. A publicly traded company since 1985, HCP: (i) was the first healthcare REIT selected to the S&P 500 index; (ii) has increased its dividend per share for 27 consecutive years; and (iii) is the only REIT included in the S&P 500 Dividend Aristocrats index. For more information regarding HCP, visit the Company’s website at www.hcpi.com.

 

###

 

Page 3 of 11



 

FORWARD-LOOKING STATEMENTS

 

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release which are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements include among other things, net income applicable to common shares on a diluted basis, FFO applicable to common shares on a diluted basis, and FAD applicable to common shares on a diluted basis for the full-year of 2012.  These statements are made as of the date hereof, are not guarantees of future performance and are subject to known and unknown risks, uncertainties, assumptions and other factors—many of which are out of the Company and its management’s control and difficult to forecast—that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements.  These risks and uncertainties include but are not limited to: national and local economic conditions; continued volatility in the capital markets, including changes in interest rates and the availability and cost of capital, which changes and volatility affect opportunities for profitable investments; the Company’s ability to access external sources of capital when desired and on reasonable terms; the Company’s ability to manage its indebtedness levels; changes in the terms of the Company’s indebtedness; the Company’s ability to maintain its credit ratings; the potential impact of existing and future litigation matters, including the possibility of larger than expected litigation costs and related developments; the Company’s ability to successfully integrate the operations of acquired companies; risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition and continued cooperation; competition for lessees and mortgagors (including new leases and mortgages and the renewal or rollover of existing leases); the Company’s ability to reposition its properties on the same or better terms if existing leases are not renewed or the Company exercises its right to replace an existing operator or tenant upon default; continuing reimbursement uncertainty in the post-acute/skilled nursing segment; competition in the senior housing segment specifically and in the healthcare industry in general; the ability of the Company’s operators and tenants from its senior housing segment to maintain or increase their occupancy levels and revenues; the ability of the Company’s lessees and mortgagors to maintain the financial strength and liquidity necessary to satisfy their respective obligations to the Company and other third parties; the bankruptcy, insolvency or financial deterioration of the Company’s operators, lessees, borrowers or other obligors; changes in healthcare laws and regulations, including the impact of future or pending healthcare reform, and other changes in the healthcare industry which affect the operations of the Company’s lessees or obligors, including changes in the federal budget resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; the Company’s ability to recruit and retain key management personnel; costs of compliance with regulations and environmental laws affecting the Company’s properties; changes in tax laws and regulations; changes in the financial position or business strategies of HCR ManorCare; the Company’s ability and willingness to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations; changes in rules governing financial reporting, including new accounting pronouncements; and other risks described from time to time in the Company’s Securities and Exchange Commission filings. The Company assumes no, and hereby disclaims any, obligation to update any of the foregoing or any other forward-looking statements as a result of new information or new or future developments, except as otherwise required by law.

 

CONTACT

 

HCP

Timothy M. Schoen

Executive Vice President and Chief Financial Officer

(562) 733-5309

 

Page 4 of 11



 

HCP, Inc.

 

Consolidated Balance Sheets

 

In thousands, except share and per share data

(Unaudited)

 

 

 

December 31,

 

December 31,

 

 

 

2011

 

2010

 

Assets

 

 

 

 

 

Real estate:

 

 

 

 

 

Buildings and improvements

 

$

8,937,492

 

$

8,189,309

 

Development costs and construction in progress

 

190,590

 

144,116

 

Land

 

1,731,327

 

1,572,744

 

Accumulated depreciation and amortization

 

(1,473,977

)

(1,245,996

)

Net real estate

 

9,385,432

 

8,660,173

 

 

 

 

 

 

 

Net investment in direct financing leases

 

6,727,777

 

609,661

 

Loans receivable, net

 

110,253

 

2,002,866

 

Investments in and advances to unconsolidated joint ventures

 

224,052

 

195,847

 

Accounts receivable, net of allowance of $1,341 and $5,150, respectively

 

26,681

 

34,504

 

Cash and cash equivalents

 

33,506

 

1,036,701

 

Restricted cash

 

41,553

 

36,319

 

Intangible assets, net

 

373,763

 

316,375

 

Real estate held for sale, net

 

 

16,591

 

Other assets, net

 

485,458

 

422,886

 

 

 

 

 

 

 

Total assets

 

$

17,408,475

 

$

13,331,923

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

Bank line of credit

 

$

454,000

 

$

 

Senior unsecured notes

 

5,416,063

 

3,318,379

 

Mortgage debt

 

1,764,571

 

1,235,779

 

Other debt

 

87,985

 

92,187

 

Intangible liabilities, net

 

124,142

 

148,072

 

Accounts payable and accrued liabilities

 

275,478

 

313,806

 

Deferred revenues

 

65,614

 

77,653

 

Total liabilities

 

8,187,853

 

5,185,876

 

 

 

 

 

 

 

Preferred stock, $1.00 par value: 50,000,000 shares authorized; 11,820,000 shares issued and outstanding, liquidation preference of $25.00 per share

 

285,173

 

285,173

 

Common stock, $1.00 par value: 750,000,000 shares authorized; 408,629,444 and 370,924,887 shares issued and outstanding, respectively

 

408,629

 

370,925

 

Additional paid-in capital

 

9,383,536

 

8,089,982

 

Cumulative dividends in excess of earnings

 

(1,024,274

)

(775,476

)

Accumulated other comprehensive loss

 

(19,582

)

(13,237

)

Total stockholders’ equity

 

9,033,482

 

7,957,367

 

 

 

 

 

 

 

Joint venture partners

 

16,971

 

14,935

 

Non-managing member unitholders

 

170,169

 

173,745

 

Total noncontrolling interests

 

187,140

 

188,680

 

 

 

 

 

 

 

Total equity

 

9,220,622

 

8,146,047

 

 

 

 

 

 

 

Total liabilities and equity

 

$

17,408,475

 

$

13,331,923

 

 

Page 5 of 11



 

HCP, Inc.

 

Consolidated Statements of Income

 

In thousands, except per share data

(Unaudited)

 

 

 

Three Months Ended
December 31,

 

Year Ended
December 31,

 

 

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

Rental and related revenues

 

$

248,521

 

$

236,522

 

$

1,015,867

 

$

917,579

 

Tenant recoveries

 

22,494

 

21,856

 

92,259

 

89,012

 

Resident fees and services

 

35,305

 

17,318

 

50,619

 

32,596

 

Income from direct financing leases

 

154,151

 

12,200

 

464,704

 

49,438

 

Interest income

 

665

 

52,159

 

99,864

 

160,163

 

Investment management fee income

 

468

 

911

 

2,073

 

4,666

 

Total revenues

 

461,604

 

340,966

 

1,725,386

 

1,253,454

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

87,362

 

77,820

 

356,834

 

311,218

 

Interest expense

 

101,433

 

68,354

 

419,337

 

288,650

 

Operating

 

69,049

 

58,341

 

220,172

 

210,202

 

General and administrative

 

19,678

 

18,008

 

96,150

 

83,048

 

Litigation settlement

 

125,000

 

 

125,000

 

 

Impairments (recoveries)

 

 

 

15,400

 

(11,900

)

Total costs and expenses

 

402,522

 

222,523

 

1,232,893

 

881,218

 

 

 

 

 

 

 

 

 

 

 

Other income (expense), net

 

(4,720

)

8,667

 

12,338

 

15,818

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes and equity income from and impairments of investments in unconsolidated joint ventures

 

54,362

 

127,110

 

504,831

 

388,054

 

Income taxes

 

(960

)

1,397

 

(1,249

)

(412

)

Equity income from unconsolidated joint ventures

 

13,952

 

692

 

46,750

 

4,770

 

Impairments of investments in unconsolidated joint ventures

 

 

 

 

(71,693

)

Income from continuing operations

 

67,354

 

129,199

 

550,332

 

320,719

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations:

 

 

 

 

 

 

 

 

 

Income before gain on sales of real estate, net of income taxes

 

326

 

454

 

1,055

 

3,751

 

Gain on sales of real estate, net of income taxes

 

3,107

 

15,873

 

3,107

 

19,925

 

Total discontinued operations

 

3,433

 

16,327

 

4,162

 

23,676

 

 

 

 

 

 

 

 

 

 

 

Net income

 

70,787

 

145,526

 

554,494

 

344,395

 

Noncontrolling interests’ share in earnings

 

(2,943

)

(3,609

)

(15,603

)

(13,686

)

Net income attributable to HCP, Inc.

 

67,844

 

141,917

 

538,891

 

330,709

 

Preferred stock dividends

 

(5,282

)

(5,282

)

(21,130

)

(21,130

)

Participating securities’ share in earnings

 

(566

)

(433

)

(2,459

)

(2,081

)

 

 

 

 

 

 

 

 

 

 

Net income applicable to common shares

 

$

61,996

 

$

136,202

 

$

515,302

 

$

307,498

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per common share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.14

 

$

0.37

 

$

1.28

 

$

0.93

 

Discontinued operations

 

0.01

 

0.05

 

0.01

 

0.08

 

Net income applicable to common shares

 

$

0.15

 

$

0.42

 

$

1.29

 

$

1.01

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per common share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.14

 

$

0.37

 

$

1.28

 

$

0.92

 

Discontinued operations

 

0.01

 

0.05

 

0.01

 

0.08

 

Net income applicable to common shares

 

$

0.15

 

$

0.42

 

$

1.29

 

$

1.00

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares used to calculate earnings per common share:

 

 

 

 

 

 

 

 

 

Basic

 

407,907

 

324,361

 

398,446

 

305,574

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

409,730

 

325,985

 

400,218

 

306,900

 

 

Page 6 of 11



 

HCP, Inc.

 

Consolidated Statements of Cash Flows

 

In thousands

(Unaudited)

 

 

 

Year Ended
December 31,

 

 

 

2011

 

2010

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

554,494

 

$

344,395

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization of real estate, in-place lease and other intangibles:

 

 

 

 

 

Continuing operations

 

356,834

 

311,218

 

Discontinued operations

 

561

 

2,229

 

Amortization of above and below market lease intangibles, net

 

(4,510

)

(6,378

)

Amortization of deferred compensation

 

20,034

 

14,924

 

Amortization of debt premiums, discounts and issuance costs, net

 

25,769

 

9,856

 

Straight-line rents

 

(59,173

)

(47,243

)

Loan and direct financing lease interest accretion

 

(93,003

)

(69,645

)

Deferred rental revenues

 

(2,319

)

(3,984

)

Equity income from unconsolidated joint ventures

 

(46,750

)

(4,770

)

Distributions of earnings from unconsolidated joint ventures

 

3,273

 

5,373

 

Gain upon consolidation of joint venture

 

(7,769

)

 

Marketable securities (gains) losses, net

 

5,396

 

(14,597

)

Gain upon settlement of loans receivable

 

(22,812

)

 

Gain on sale of real estate

 

(3,107

)

(19,925

)

Derivative (gains) losses, net

 

(1,226

)

1,302

 

Impairments, net of recoveries

 

15,400

 

59,793

 

Changes in:

 

 

 

 

 

Accounts receivable, net

 

2,590

 

9,222

 

Other assets

 

27,582

 

(6,341

)

Accounts payable and accrued liabilities

 

(47,103

)

(4,931

)

Net cash provided by operating activities

 

724,161

 

580,498

 

Cash flows from investing activities:

 

 

 

 

 

Cash used in the HCR ManorCare Acquisition, net of cash acquired

 

(4,026,556

)

 

Cash used in the HCP Ventures II purchase, net of cash acquired

 

(135,550

)

 

Other acquisitions and development of real estate

 

(198,385

)

(304,847

)

Leasing costs and tenant and capital improvements

 

(52,903

)

(97,930

)

Proceeds from sales of real estate, net

 

19,183

 

32,284

 

Purchase of an interest in and contributions to unconsolidated joint ventures

 

(95,000

)

(6,565

)

Distributions in excess of earnings from unconsolidated joint ventures

 

2,408

 

4,365

 

Purchases of marketable equity securities

 

(22,449

)

 

Proceeds from the sales of marketable securities

 

 

179,215

 

Principal repayments on loans receivable and direct financing leases

 

303,941

 

63,953

 

Investments in loans receivable

 

(369,939

)

(298,085

)

Increase in restricted cash

 

(5,234

)

(3,319

)

Net cash used in investing activities

 

(4,580,484

)

(430,929

)

Cash flows from financing activities:

 

 

 

 

 

Net borrowings under bank line of credit

 

454,000

 

 

Repayment of term loan

 

 

(200,000

)

Issuance of senior unsecured notes

 

2,400,000

 

 

Repayment of senior unsecured notes

 

(292,265

)

(206,422

)

Repayments of mortgage and other secured debt

 

(169,783

)

(636,096

)

Debt discounts and issuance costs

 

(43,716

)

(11,850

)

Net proceeds from the issuance of common stock and exercise of options

 

1,327,813

 

2,426,900

 

Dividends paid on common and preferred stock

 

(787,689

)

(590,735

)

Sale of noncontrolling interests

 

14,087

 

8,395

 

Purchase of noncontrolling interests

 

(34,104

)

 

Distributions to noncontrolling interests

 

(15,215

)

(15,319

)

Net cash provided by financing activities

 

2,853,128

 

774,873

 

Net increase (decrease) in cash and cash equivalents

 

(1,003,195

)

924,442

 

Cash and cash equivalents, beginning of year

 

1,036,701

 

112,259

 

Cash and cash equivalents, end of year

 

$

33,506

 

$

1,036,701

 

 

Page 7 of 11



 

HCP, Inc.

 

Funds From Operations(1)

 

In thousands, except per share data

(Unaudited)

 

 

 

Three Months Ended
December 31,

 

Year Ended
December 31,

 

 

 

2011

 

2010

 

2011

 

2010(2)

 

 

 

 

 

 

 

 

 

 

 

Net income applicable to common shares

 

$

61,996

 

$

136,202

 

$

515,302

 

$

307,498

 

Depreciation and amortization of real estate, in-place lease and other intangibles:

 

 

 

 

 

 

 

 

 

Continuing operations

 

87,362

 

77,820

 

356,834

 

311,218

 

Discontinued operations

 

5

 

237

 

561

 

2,229

 

Direct financing lease (“DFL”) depreciation

 

2,961

 

 

8,840

 

 

Gain on sales of real estate

 

(3,107

)

(15,873

)

(3,107

)

(19,925

)

Gain upon consolidation of joint venture

 

 

 

(7,769

)

 

Impairments of investments in joint ventures

 

 

 

 

71,693

 

Equity income from unconsolidated joint ventures

 

(13,952

)

(692

)

(46,750

)

(4,770

)

FFO from unconsolidated joint ventures

 

16,479

 

5,579

 

56,887

 

25,288

 

Noncontrolling interests’ and participating securities’ share in earnings

 

3,509

 

4,042

 

18,062

 

15,767

 

Noncontrolling interests’ and participating securities’ share in FFO

 

(4,675

)

(4,704

)

(20,953

)

(18,361

)

FFO applicable to common shares

 

$

150,578

 

$

202,611

 

$

877,907

 

$

690,637

 

Distributions on dilutive convertible units

 

 

2,987

 

6,916

 

11,847

 

Diluted FFO applicable to common shares

 

$

150,578

 

$

205,598

 

$

884,823

 

$

702,484

 

Diluted FFO per common share

 

$

0.37

 

$

0.62

 

$

2.19

 

$

2.25

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares used to calculate diluted FFO per share

 

409,730

 

331,960

 

403,864

 

312,797

 

Impact of adjustments to FFO:

 

 

 

 

 

 

 

 

 

Litigation settlement charge(3)

 

$

125,000

 

$

 

$

125,000

 

$

 

Other impairments (recoveries)(4)

 

 

 

15,400

 

(11,900

)

Merger-related items(5)

 

 

4,339

 

26,596

 

4,339

 

 

 

$

125,000

 

$

4,339

 

$

166,996

 

$

(7,561

)

FFO as adjusted applicable to common shares

 

$

275,578

 

$

206,950

 

$

1,044,903

 

$

683,076

 

Distributions on dilutive convertible units and other

 

2,858

 

2,970

 

11,646

 

12,089

 

Diluted FFO as adjusted applicable to common shares

 

$

278,436

 

$

209,920

 

$

1,056,549

 

$

695,165

 

Per common share impact of adjustments on diluted FFO (3)(4)(5)

 

$

0.30

 

$

0.02

 

$

0.50

 

$

(0.02

)

Diluted FFO as adjusted per common share

 

$

0.67

 

$

0.64

 

$

2.69

 

$

2.23

 

Weighted average shares used to calculate diluted FFO as adjusted per share

 

415,624

 

325,960

 

393,237

 

311,285

 

 


(1) The Company believes FFO is an important supplemental measure of operating performance for a real estate investment trust. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. The term FFO was designed by the real estate investment trust industry to address this issue. FFO is defined as net income applicable to common shares (computed in accordance with U.S. generally accepted accounting principles or “GAAP”), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income. The Company’s computation of FFO may not be comparable to FFO reported by other real estate investment trusts that do not define the term in accordance with the current National Association of Real Estate Investment Trusts’ (“NAREIT”) definition or that have a different interpretation of the current NAREIT definition from the Company. FFO as adjusted represents FFO before the impact of litigation settlement charges, other impairments, other impairment recoveries and merger-related items (defined below). Management believes FFO as adjusted is a useful alternative measurement. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income.

 

(2)     NAREIT recently issued updated reporting guidance that directs companies, for their computation of NAREIT FFO, to exclude impairments of depreciable real estate and other assets when write-downs are driven by measurable decreases in the fair value of real estate holdings (e.g., investments in joint ventures that primarily hold real estate). Previously, the Company’s calculation of FFO (consistent with NAREIT’s previous guidance) did not exclude impairments of, or related to, depreciable real estate. Consistent with this current NAREIT reporting guidance, the Company has restated its 2010 FFO amounts.

 

(3)     This charge of $125 million, or $0.31 per share, during the year ended December 31, 2011 relates to the Ventas settlement. See the “Litigation” section of this release for additional information regarding this settlement.

 

(4)   Other impairments of $15.4 million, or $0.04 per share, during the year ended December 31, 2011 relates to our senior secured loan to Cirrus Health. Recoveries of $11.9 million, or $0.04 per share, relate to portions of previous impairment charges related to investments in three direct financing leases (non-depreciable due to lessee purchase option) and a participation interest in a senior construction loan related to Erickson Retirement Communities.

 

(5)     2011 merger-related items represents the aggregate impact of $0.15 per share include the following: (i) direct transaction costs, (ii) prefunding activities related to the impact of senior unsecured notes and common stock issued to prefund the HCR ManorCare Acquisition, partially offset by (iii) income related to gains upon the reinvestment of the Company’s debt investment in HCR ManorCare and other miscellaneous items. 2010 merger-related items of $0.02 per share include the following: (i) direct transaction costs; and (ii) prefunding activities related to the impact of common stock issued to prefund the HCR ManorCare Acquisition.

 

Page 8 of 11



 

HCP, Inc.

 

Funds Available for Distribution(1)

 

In thousands, except per share data

(Unaudited)

 

 

 

Three Months Ended December 31,

 

Year Ended
December 31,

 

 

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

 

 

 

 

 

 

FFO as adjusted applicable to common shares

 

$

275,578

 

$

206,950

 

$

1,044,903

 

$

683,076

 

Amortization of above and below market lease intangibles, net

 

(1,239

)

(1,041

)

(4,510

)

(6,378

)

Amortization of deferred compensation (stock-based)

 

4,748

 

3,618

 

20,034

 

14,924

 

Amortization of debt premiums, discounts and issuance costs, net(2)

 

3,651

 

1,840

 

13,716

 

9,078

 

Straight-line rents

 

(12,237

)

(14,374

)

(59,173

)

(47,243

)

DFL accretion(3)

 

(25,499

)

(2,300

)

(74,007

)

(10,641

)

DFL depreciation

 

(2,961

)

 

(8,840

)

 

Deferred revenues – tenant improvement related

 

(237

)

(929

)

(2,371

)

(3,714

)

Deferred revenues – additional rents (SAB 104)

 

(798

)

(810

)

52

 

(270

)

Leasing costs and tenant and capital improvements(4)

 

(21,131

)

(20,853

)

(52,903

)

(54,237

)

Joint venture and other FAD adjustments(3)

 

(16,985

)

(809

)

(46,250

)

(6,143

)

FAD applicable to common shares

 

$

202,890

 

$

171,292

 

$

830,651

 

$

578,452

 

 

 

 

 

 

 

 

 

 

 

Distributions on dilutive convertible units

 

1,758

 

1,714

 

6,916

 

6,676

 

 

 

 

 

 

 

 

 

 

 

Diluted FAD applicable to common shares

 

$

204,648

 

$

173,006

 

$

837,567

 

$

585,128

 

 

 

 

 

 

 

 

 

 

 

Diluted FAD per common share

 

$

0.50

 

$

0.53

 

$

2.14

 

$

1.89

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares used to calculate diluted FAD per common share

 

413,338

 

323,644

 

390,944

 

308,953

 

 


(1) Funds Available for Distribution (“FAD”) is defined as FFO as adjusted after excluding the impact of the following: (i) straight-line rents; (ii) amortization of acquired above/below market lease intangibles; (iii) amortization of debt premiums, discounts and issuance costs; (iv) amortization of stock—based compensation expense; (v) accretion and depreciation related to direct financing leases; and (vi) deferred revenues. Further, FAD is computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements and includes similar adjustments to compute the Company’s share of FAD from its unconsolidated joint ventures. Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, HCP’s FAD may not be comparable to those reported by other REITs. Although HCP’s FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of the Company’s ability to fund its ongoing dividend payments. In addition, management believes that in order to further understand and analyze the Company’s liquidity, FAD should be compared with cash flows as determined in accordance with GAAP and presented in its consolidated financial statements. FAD does not represent cash generated from operating activities determined in accordance with GAAP, and FAD should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of the Company’s performance, as an alternative to net cash flows from operating activities (determined in accordance with GAAP), or as a measure of the Company’s liquidity.

 

(2) Excludes $11.3 million related to the write-off of unamortized loan fees related to an expired bridge loan commitment and $0.8 million related to the amortization of deferred issuance costs of the senior notes, which costs are included in merger-related items for the year ended December 31, 2011.

 

(3) For the quarter and year ended December 31, 2011, DFL accretion reflects an elimination of $14.5 million and $42.2 million respectively. Our ownership interest in HCR ManorCare OpCo is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to our ownership in HCR ManorCare OpCo. Further, our share of earnings from HCR ManorCare OpCo (equity income) increases for the corresponding elimination of related lease expense recognized at the HCR ManorCare OpCo level, which we present as a non-cash joint venture FAD adjustment.

 

(4) Excludes $41 million ($2 million in 4Q2010 and $39 million in 3Q2010) of deferred leasing costs related to the buyout of management contracts for 27 Sunrise-managed communities. On November 1, 2010, we exercised our rights to terminate management contracts relating to 27 senior housing communities previously operated by Sunrise; our net investment to acquire these termination rights was $41 million, which consisted of a $50 million payment to Sunrise that was partially offset for certain working capital acquired in conjunction with this transaction.

 

Page 9 of 11



 

HCP, Inc.

 

Net Operating Income and Same Property Performance(1)(2)

 

Dollars in thousands

(Unaudited)

 

 

 

Three Months Ended
December 31,

 

Year Ended
December 31,

 

 

 

2011

 

2010

 

2011

 

2010

 

Net income

 

$

70,787

 

$

145,526

 

$

554,494

 

$

344,395

 

Interest income

 

(665

)

(52,159

)

(99,864

)

(160,163

)

Investment management fee income

 

(468

)

(911

)

(2,073

)

(4,666

)

Depreciation and amortization

 

87,362

 

77,820

 

356,834

 

311,218

 

Interest expense

 

101,433

 

68,354

 

419,337

 

288,650

 

General and administrative

 

19,678

 

18,008

 

96,150

 

83,048

 

Litigation settlement

 

125,000

 

 

125,000

 

 

Impairments (recoveries)

 

 

 

15,400

 

(11,900

)

Other (Income) expense, net

 

4,720

 

(8,667

)

(12,338

)

(15,818

)

Income taxes

 

960

 

(1,397

)

1,249

 

412

 

Equity income from unconsolidated joint ventures

 

(13,952

)

(692

)

(46,750

)

(4,770

)

Impairments of investments in unconsolidated joint ventures

 

 

 

 

71,693

 

Total discontinued operations, net of income taxes

 

(3,433

)

(16,327

)

(4,162

)

(23,676

)

NOI(1)

 

$

391,422

 

$

229,555

 

$

1,403,277

 

$

878,423

 

Straight-line rents

 

(12,237

)

(14,374

)

(59,173

)

(47,243

)

DFL accretion

 

(25,499

)

(2,300

)

(74,007

)

(10,641

)

Amortization of above and below market lease intangibles, net

 

(1,239

)

(1,041

)

(4,510

)

(6,378

)

Lease termination fees

 

(2,457

)

(2,500

)

(5,873

)

(7,665

)

NOI adjustments related to discontinued operations

 

 

 

 

27

 

Adjusted NOI(1)

 

$

349,990

 

$

209,340

 

$

1,259,714

 

$

806,523

 

Non-SPP adjusted NOI(1)(2)

 

(133,519

)

2,400

 

(422,158

)

(955

)

Same property portfolio adjusted NOI(1)(2)

 

$

216,471

 

$

211,740

 

$

837,556

 

$

805,568

 

 

 

 

 

 

 

 

 

 

 

Adjusted NOI % change – SPP

 

2.2

%

 

 

4.0

%

 

 

 


(1) The Company believes Net Operating Income from Continuing Operations (“NOI”) provides investors relevant and useful information because it measures the operating performance of the Company’s leased properties (i.e., real estate and DFLs) at the property level on an unleveraged basis. NOI is used to evaluate the operating performance of leased properties and SPP. The Company uses NOI and NOI, as adjusted, to make decisions about resource allocations, to assess and compare property level performance, and evaluate SPP. The Company believes that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since it does not reflect the aforementioned excluded items. Further, NOI may not be comparable to that of other real estate investment trusts, as they may use different methodologies for calculating NOI.

 

NOI is defined as rental revenues, including tenant reimbursements, resident fees and services, and income from direct financing leases, less property level operating expenses. NOI excludes interest income, investment management fee income, depreciation and amortization, interest expense, general and administrative expenses, litigation settlement, impairments, impairment recoveries, other income, net, income tax expenses, equity income from unconsolidated joint ventures and discontinued operations. NOI, as adjusted, is calculated as NOI eliminating the effects of straight-line rents, DFL accretion, amortization of above and below market lease intangibles, and lease termination fees. NOI, as adjusted, is sometimes referred to as “adjusted NOI” or “cash NOI.”

 

(2) Same property statistics allow management to evaluate the performance of the Company’s leased property portfolio under a consistent population, which eliminates the changes in the composition of our portfolio of properties. The Company identifies its SPP as stabilized properties that are, and remained, in operations for the duration of the year-over-year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations to be included in the Company’s same property portfolio. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

 

Page 10 of 11



 

HCP, Inc.

 

Projected Future Operations(1)

 

(Unaudited)

 

 

 

Full Year 2012

 

 

 

Low

 

High

 

 

 

 

 

 

 

Diluted earnings per common share

 

$

1.81

 

$

1.87

 

Real estate depreciation and amortization

 

0.85

 

0.85

 

DFL depreciation

 

0.03

 

0.03

 

Joint venture FFO adjustments

 

0.01

 

0.01

 

Diluted FFO per common share

 

$

2.70

 

$

2.76

 

Amortization of net below market lease intangibles and deferred revenues

 

(0.01

)

(0.01

)

Stock-based compensation

 

0.05

 

0.05

 

Amortization of debt premiums, discounts and issuance costs, net

 

0.04

 

0.04

 

Straight-line rents

 

(0.10

)

(0.10

)

DFL accretion(2)

 

(0.23

)

(0.23

)

DFL depreciation

 

(0.03

)

(0.03

)

Leasing costs and tenant and capital improvements

 

(0.14

)

(0.14

)

Joint venture and other FAD adjustments(2)

 

(0.14

)

(0.14

)

Diluted FAD per common share

 

$

2.14

 

$

2.20

 

 


(1)     Except as otherwise noted above, the foregoing projections reflect management’s view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, development items and the earnings impact of the events referenced in this release. Except as otherwise noted, these estimates do not reflect the potential impact of future acquisitions, dispositions, other impairments or recoveries, the future bankruptcy or insolvency of the Company’s operators, lessees, borrowers or other obligors, the effect of any future restructuring of the Company’s contractual relationships with such entities, gains or losses on marketable securities, ineffectiveness related to our cash flow hedges, offerings of debt or existing and future litigation matters including the possibility of larger than expected litigation costs and related developments. There can be no assurance that the Company’s actual results will not differ materially from the estimates set forth above. The aforementioned ranges represent management’s best estimate of results based upon the underlying assumptions as of the date of this press release. Except as otherwise required by law, management assumes no, and hereby disclaims any, obligation to update any of the foregoing projections as a result of new information or new or future developments.

 

(2)     Our ownership interest in HCR ManorCare OpCo is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to our ownership in HCR ManorCare OpCo. Further, our share of earnings from HCR ManorCare OpCo (equity income) increases for the corresponding elimination of related lease expense recognized at the HCR ManorCare OpCo level, which we present as a non-cash joint venture FAD adjustment..

 

Page 11 of 11